Information versus experience: A comparison of an information leaflet on antidepressants with lay experience of treatment

Patient Education and Counseling

Volumn 54, Issue 3, 2004, Pages 361-368

  Grime, Janet ^a   Pollock, Kristian ^a  

^a KEELE UNIVERSITY   (United Kingdom)

Author keywords

Antidepressants; Experience; Information; Patient; Qualitative

Indexed keywords

ANTIDEPRESSANT AGENT;

CONFERENCE PAPER; CONTROLLED STUDY; DEPRESSION; EXPERIENCE; FEMALE; HUMAN; INTERVIEW; MALE; MEDICAL LITERATURE; MEDICINE; PATIENT EDUCATION; PRESCRIPTION; PRIORITY JOURNAL; SELF HELP;

ANTIDEPRESSIVE AGENTS; GREAT BRITAIN; HUMANS; INFORMATION DISSEMINATION; PAMPHLETS; PATIENT EDUCATION; QUALITATIVE RESEARCH; SELF-HELP GROUPS; TEACHING MATERIALS;

EID: 8444220801     PISSN: 07383991     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pec.2004.02.003     Document Type: Conference Paper

References (31)

1. Skelton A. Evolution not revolution? The struggle for the recognition and development of patient education in the UK. Patient Educ. Couns. 44:2001;23-27
2. Dixon-Woods M. Writing wrongs? An analysis of published discourses about the use of patient information leaflets. Soc. Sci. Med. 52:2001;1417-1432
3. Coulter A., Entwistle V., Gilbert G. Sharing decisions with patient: is the information good enough? Br. Med. J. 318:1999;318-322
4. Raynor T.K., Britten N. Medicine information leaflets fail concordance test. Br. Med. J. 322:2001;1541
5. Ford S., Schofield T., Hope T. Barriers to the evidence-based patient choice (EBPC) consultation. Patient. Educ. Couns. 47:2002;179-185
6. Marinker M, Blenkinsopp A, Bond C, Britten N, Feely M, George C., et al., editors. From compliance to concordance: achieving shared goals in medicine taking. London: Royal Pharmaceutical Society of Great Britain; 1997.
7. Jorm A.F. Mental health literacy. Public knowledge and beliefs about mental disorders. Br. J. Psychiat. 177:2000;396-401
8. Lingam R., Scott J. Treatment non-adherence in affective disorders. Acta Psychiat. Scand. 105:2002;164-172
9. Priest R.G., Vize C., Roberts A., Roberts M., Tylee A. Lay people's attitude to treatment of depression: results of opinion poll for Defeat Depression Campaign just before its launch. Br. Med. J. 313:1996;858-859
10. Department of Health, The expert patient: a new approach to chronic disease management for the 21st Century. London: August 2001.
11. Watt A, Rodmell S. Community involvement in health promotion: progress or panacea? In: Beattie A, Gott M, Jones L, Sidell M, editors. Health and wellbeing a reader. The Open University; 1993.
12. Donoghue J. Depression and Antidepressants. Depression Alliance; 1996. Revised in 2002 by Bazire S and accessed from: http://www.depressionalliance. org/publications/DA_Anti-Dep.pdf.
13. Grime J., Pollock K. Patients' ambivalence about taking antidepressants: a qualitative study. Pharm. J. 271:2003;516-519
14. Arthur V.A.M. Written patient information: a review of the literature. J. Adv. Nurs. 21:1995;1081-1086
15. UMDS MSc in General Practice Teaching Group. 'You're depressed' 'No I'm not' GPs' and patients' different models of depression, Br J Gen Pract 49:1999;123-4.
16. Brown C., Dunbar-Jacob J., Palenchar D.R., Kelleher K.J., Bruehlman R.D., Sereika S., et al. Primary care patients' personal illness models for depression: a preliminary investigation. Fam. Pract. 18:2001;314-320
17. Depression Alliance, Report on the Results of a Survey Undertaken by Depression Alliance Pertaining to the Diagnosis and Treatment of Depression in the United Kingdom. Depression Alliance; December 1997.
18. Herxheimer A. Relationship between the pharmaceutical industry and patients' organisations. Br. Med. J. 326:2003;1208-1210
19. Mendlewicz J. Optimising antidepressant use in clinical practice: towards criteria for antidepressant selection. Br. J. Psychiat. 179(Suppl):2001;S1-S3
20. Moncrieff J. The antidepressant debate. Br. J. Psychiat. 180:2002;193-194
21. Andrews G. Placebo response in depression: bane of research, boon to therapy. Br. J. Psychiat. 178:2001;192-194
22. Medawar C., Hexheimer A., Bell A., Jofre S. Paroxetine. Panorama and user reporting of ADRs: consumer intelligence matters in clinical practice and post-marketing drug surveillance. Int. J. Risk Safety Med. 15:2002;161-169
23. Barbui C., Hotopf M. Forty years of antidepressant drug trials. Acta Psychiat. Scand. 104:2001;92-95
24. Gabe J. The history of tranquiliser use. In: Mental health matters Heller T, Reynolds J, Gomm R, Muston R, Pattison S, editors. The Open University; 1996.
25. Rogers A., May C., Oliver D. Experiencing depression, experiencing the depressed: the separate worlds of patients and doctors. J. Mental Health. 10(3):2001;317-333
26. Karp D.A. Living with depression: illness and identity turning points. Qual. Health Res. 4:1994;6-31
27. Kennedy A.P., Rogers A.E. Improving patient involvement in chronic disease management: the views of patients, GPs and specialists on a guide book for ulcerative colitis. Patient. Educ. Couns. 47:2002;257-263
28. Demyttenaere K., Enzlin P., Dewe W., Boulanger B., De Bie J., De Troyer W., et al. Compliance with antidepressants in a primary care setting, 1. Beyond lack of efficacy and adverse events. J. Clin. Psychiat. 62(Suppl 22):2001;30-33
29. Peveler R., George C., Kinmouth A.L., Campbell M., Thomson C. Effect of antidepressant drug counselling and information leaflets on adherence to drug treatment in primary care: randomised control trial. Br. Med. J. 319:1999;612-615
30. Garrud P., Wood M., Stainsby L. Impact of risk information in a patient education leaflet. Patient Educ. Couns. 43:2001;301-304
31. Coulter A., Entwistle V., Gilbert D., Informing patients. An assessment of the quality of patient information materials. King's Fund; 1998.